{"id":29491,"date":"2025-08-06T08:42:10","date_gmt":"2025-08-06T11:42:10","guid":{"rendered":"https:\/\/nogoyatimes.com\/?p=29491"},"modified":"2025-08-06T08:42:10","modified_gmt":"2025-08-06T11:42:10","slug":"vacuna-contra-el-cancer-rusia-comenzara-los-ensayos-en-humanos","status":"publish","type":"post","link":"https:\/\/nogoyatimes.com\/?p=29491","title":{"rendered":"Vacuna contra el c\u00e1ncer: Rusia comenzar\u00e1 los ensayos en humanos"},"content":{"rendered":"<header class=\"cl-24 header-interior interior-top-1\">Este tratamiento se crea a partir de los datos gen\u00e9ticos de cada individuo. Debido a su naturaleza personalizada, el medicamento es espec\u00edfico para cada paciente y no puede ser utilizado por ninguna otra persona.\u00a0\u00a0<\/header>\n<header><\/header>\n<header><i>Vacuna rusa contra el c\u00e1ncer<\/i><\/p>\n<p>El Centro Nacional de Investigaci\u00f3n de Epidemiolog\u00eda y Microbiolog\u00eda Gamaleya de Rusia anunci\u00f3 que trabaja en una vacuna contra el c\u00e1ncer que podr\u00eda comenzar a ser administrada a los primeros pacientes\u00a0<b>en los pr\u00f3ximos meses<\/b>. El director del centro, Alex\u00e1nder Gu\u00edntsburg, confirm\u00f3 que el tratamiento experimental se aplicar\u00e1 inicialmente a un grupo de personas con\u00a0<b>melanoma.<\/b><\/p>\n<p>&nbsp;<\/p>\n<p>Gu\u00edntsburg explic\u00f3 a la agencia de noticias RIA Novosti que este trabajo se llevar\u00e1 a cabo en colaboraci\u00f3n con el Instituto de Investigaci\u00f3n Oncol\u00f3gica Guerzen de Mosc\u00fa y el Centro Nacional de Investigaci\u00f3n M\u00e9dica Oncol\u00f3gica Bloj\u00edn. La funci\u00f3n del<b>\u00a0Centro Gamaleya<\/b>\u00a0se limitar\u00e1 a la producci\u00f3n de la vacuna.<\/p>\n<p>&nbsp;<\/p>\n<p>Seg\u00fan revelaron los cient\u00edficos a cargo, este tratamiento se crea a partir de los datos gen\u00e9ticos de cada individuo. Debido a su naturaleza personalizada,\u00a0<b>el medicamento es espec\u00edfico para cada paciente\u00a0<\/b>y no puede ser utilizado por ninguna otra persona.<\/p>\n<p>&nbsp;<\/p>\n<p>El director del centro de investigaci\u00f3n mencion\u00f3 que esta particularidad motiv\u00f3 al Gobierno ruso a emitir un decreto para establecer nuevas regulaciones para su uso.\u00a0<i>&#8220;Por eso, el Gobierno emiti\u00f3 un decreto correspondiente a principios de a\u00f1o. Y existen regulaciones (del uso de la vacuna) completamente diferentes, que se est\u00e1n aplicando por primera vez&#8221;<\/i>, se\u00f1al\u00f3 Gu\u00edntsburg.<\/p>\n<p>&nbsp;<\/p>\n<p>El cient\u00edfico tambi\u00e9n revel\u00f3 que la nueva vacuna despert\u00f3 el inter\u00e9s de otros pa\u00edses, que han enviado comunicaciones al equipo que trabaja en su desarrollo para conocer m\u00e1s detalles.<\/p>\n<h2><\/h2>\n<p>En 2025, el desarrollo de vacunas contra el c\u00e1ncer ocup\u00f3 un rol central en la investigaci\u00f3n m\u00e9dica del pa\u00eds europeo. Rusia est\u00e1 avanzando en dos l\u00edneas de investigaci\u00f3n principales en este campo. La primera es la viroterapia oncol\u00edtica, que utiliza virus con capacidad para destruir c\u00e9lulas malignas. La segunda es el empleo de la tecnolog\u00eda de ARNm. El trabajo del Centro Gamaleya se basa en esta \u00faltima.<\/p>\n<p>&nbsp;<\/p>\n<p>La vacuna de Gamaleya utiliza una plataforma de ARNm (\u00e1cido ribonucleico mensajero). El ARNm es una mol\u00e9cula que transfiere el c\u00f3digo gen\u00e9tico desde el ADN, que se encuentra en el n\u00facleo celular, hacia los ribosomas en el citoplasma. La funci\u00f3n de esta vacuna es\u00a0<b>entrenar al sistema inmunitario del cuerpo para que reconozca y ataque a las c\u00e9lulas cancerosas.<\/b><\/p>\n<p>&nbsp;<\/p>\n<p>Este mecanismo de acci\u00f3n induce al organismo a generar c\u00e9lulas que identifican prote\u00ednas extra\u00f1as. Estas c\u00e9lulas se adhieren al tumor y liberan enzimas activas que luego perforan las c\u00e9lulas afectadas, mientras que otras penetran a trav\u00e9s de esas aberturas para destruir las prote\u00ednas tumorales. Este proceso busca destruir tanto el tumor como las c\u00e9lulas que pueden causar met\u00e1stasis.<\/p>\n<p><img data-src=\"https:\/\/www.cronica.com.ar\/__export\/1754296041872\/sites\/cronica\/img\/2025\/08\/04\/captura_de_pantalla_2025-08-04_052309_-1-.png_48859681.png\" \/><\/p>\n<p>Adem\u00e1s de la vacuna de Gamaleya, el Centro Nacional de Investigaci\u00f3n Radiol\u00f3gica M\u00e9dica del Ministerio de Salud ruso comenz\u00f3 los primeros ensayos cl\u00ednicos de otra vacuna, EnteroMix, en junio. Este medicamento se basa en el uso de virus oncol\u00edticos, espec\u00edficamente enterovirus, para destruir las c\u00e9lulas cancerosas. Fuente: El Once<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-22637\" src=\"http:\/\/nogoyatimes.com\/wp-content\/uploads\/2024\/12\/facello-seguros-e1735308368163.jpeg\" alt=\"\" width=\"360\" height=\"118\" \/><\/p>\n<p style=\"text-align: center\"><a href=\"http:\/\/nogoyaradios.com\/\"><strong>Escuch\u00e1 La 100 #Nogoy\u00e1<\/strong><\/a><strong>\u00a0en vivo<\/strong><strong>\u00a0Seguinos en\u00a0<\/strong><a href=\"https:\/\/www.facebook.com\/nogoyaradiosnog\"><strong>Facebook<\/strong><\/a><strong>\u00a0Seguinos en\u00a0<\/strong><a href=\"https:\/\/twitter.com\/NogoyaRadios\"><strong>Twitter<\/strong><\/a><\/p>\n<p style=\"text-align: center\"><strong><em>Nogoy\u00e1 Radios es una Agencia de Medios que cuenta con espacios publicitarios adecuados para la difusi\u00f3n de su Empresa, Profesi\u00f3n y\/o Servicios.<\/em><\/strong><a href=\"https:\/\/web.facebook.com\/hashtag\/nogoy%C3%A1\"><strong><em>#Nogoy\u00e1<\/em><\/strong><\/a><strong><em>\u00a0Radios\u00a0<\/em><\/strong><strong><em>3435-429289 \/ 3435-616203 contacto@nogoyaradios.com<\/em><\/strong><\/p>\n<\/header>\n","protected":false},"excerpt":{"rendered":"<p>Este tratamiento se crea a partir de los datos gen\u00e9ticos de cada individuo. Debido a su naturaleza personalizada, el medicamento es espec\u00edfico para cada paciente y no puede ser utilizado por ninguna otra persona.\u00a0\u00a0 Vacuna rusa contra el c\u00e1ncer El&#8230;<\/p>\n","protected":false},"author":2,"featured_media":29492,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20,3],"tags":[],"class_list":["post-29491","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-internacionales","category-noticias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vacuna contra el c\u00e1ncer: Rusia comenzar\u00e1 los ensayos en humanos - Nogoy\u00e1 Times<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nogoyatimes.com\/?p=29491\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vacuna contra el c\u00e1ncer: Rusia comenzar\u00e1 los ensayos en humanos - Nogoy\u00e1 Times\" \/>\n<meta property=\"og:description\" content=\"Este tratamiento se crea a partir de los datos gen\u00e9ticos de cada individuo. Debido a su naturaleza personalizada, el medicamento es espec\u00edfico para cada paciente y no puede ser utilizado por ninguna otra persona.\u00a0\u00a0 Vacuna rusa contra el c\u00e1ncer El...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nogoyatimes.com\/?p=29491\" \/>\n<meta property=\"og:site_name\" content=\"Nogoy\u00e1 Times\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-06T11:42:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nogoyatimes.com\/wp-content\/uploads\/2025\/08\/1-8.png\" \/>\n\t<meta property=\"og:image:width\" content=\"789\" \/>\n\t<meta property=\"og:image:height\" content=\"471\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Nogoy\u00e1 Times\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nogoy\u00e1 Times\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nogoyatimes.com\\\/?p=29491#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nogoyatimes.com\\\/?p=29491\"},\"author\":{\"name\":\"Nogoy\u00e1 Times\",\"@id\":\"https:\\\/\\\/nogoyatimes.com\\\/#\\\/schema\\\/person\\\/ada1fd8d2cdb970395179b53a1ff1759\"},\"headline\":\"Vacuna contra el c\u00e1ncer: Rusia comenzar\u00e1 los ensayos en humanos\",\"datePublished\":\"2025-08-06T11:42:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nogoyatimes.com\\\/?p=29491\"},\"wordCount\":629,\"publisher\":{\"@id\":\"https:\\\/\\\/nogoyatimes.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nogoyatimes.com\\\/?p=29491#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nogoyatimes.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/1-8.png\",\"articleSection\":[\"Internacionales\",\"Noticias\"],\"inLanguage\":\"es-AR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nogoyatimes.com\\\/?p=29491\",\"url\":\"https:\\\/\\\/nogoyatimes.com\\\/?p=29491\",\"name\":\"Vacuna contra el c\u00e1ncer: Rusia comenzar\u00e1 los ensayos en humanos - Nogoy\u00e1 Times\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nogoyatimes.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nogoyatimes.com\\\/?p=29491#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nogoyatimes.com\\\/?p=29491#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nogoyatimes.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/1-8.png\",\"datePublished\":\"2025-08-06T11:42:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nogoyatimes.com\\\/?p=29491#breadcrumb\"},\"inLanguage\":\"es-AR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nogoyatimes.com\\\/?p=29491\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es-AR\",\"@id\":\"https:\\\/\\\/nogoyatimes.com\\\/?p=29491#primaryimage\",\"url\":\"https:\\\/\\\/nogoyatimes.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/1-8.png\",\"contentUrl\":\"https:\\\/\\\/nogoyatimes.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/1-8.png\",\"width\":789,\"height\":471},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nogoyatimes.com\\\/?p=29491#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/nogoyatimes.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vacuna contra el c\u00e1ncer: Rusia comenzar\u00e1 los ensayos en humanos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nogoyatimes.com\\\/#website\",\"url\":\"https:\\\/\\\/nogoyatimes.com\\\/\",\"name\":\"Nogoy\u00e1 Times\",\"description\":\"Diario Digital de Nogoy\u00e1 Radios Productora\",\"publisher\":{\"@id\":\"https:\\\/\\\/nogoyatimes.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nogoyatimes.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es-AR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nogoyatimes.com\\\/#organization\",\"name\":\"Nogoy\u00e1 Times\",\"url\":\"https:\\\/\\\/nogoyatimes.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-AR\",\"@id\":\"https:\\\/\\\/nogoyatimes.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nogoyatimes.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/cropped-nogoyatimes-a.jpg\",\"contentUrl\":\"https:\\\/\\\/nogoyatimes.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/cropped-nogoyatimes-a.jpg\",\"width\":250,\"height\":112,\"caption\":\"Nogoy\u00e1 Times\"},\"image\":{\"@id\":\"https:\\\/\\\/nogoyatimes.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nogoyatimes.com\\\/#\\\/schema\\\/person\\\/ada1fd8d2cdb970395179b53a1ff1759\",\"name\":\"Nogoy\u00e1 Times\",\"url\":\"https:\\\/\\\/nogoyatimes.com\\\/?author=2\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vacuna contra el c\u00e1ncer: Rusia comenzar\u00e1 los ensayos en humanos - Nogoy\u00e1 Times","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nogoyatimes.com\/?p=29491","og_locale":"es_ES","og_type":"article","og_title":"Vacuna contra el c\u00e1ncer: Rusia comenzar\u00e1 los ensayos en humanos - Nogoy\u00e1 Times","og_description":"Este tratamiento se crea a partir de los datos gen\u00e9ticos de cada individuo. Debido a su naturaleza personalizada, el medicamento es espec\u00edfico para cada paciente y no puede ser utilizado por ninguna otra persona.\u00a0\u00a0 Vacuna rusa contra el c\u00e1ncer El...","og_url":"https:\/\/nogoyatimes.com\/?p=29491","og_site_name":"Nogoy\u00e1 Times","article_published_time":"2025-08-06T11:42:10+00:00","og_image":[{"width":789,"height":471,"url":"https:\/\/nogoyatimes.com\/wp-content\/uploads\/2025\/08\/1-8.png","type":"image\/png"}],"author":"Nogoy\u00e1 Times","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Nogoy\u00e1 Times","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nogoyatimes.com\/?p=29491#article","isPartOf":{"@id":"https:\/\/nogoyatimes.com\/?p=29491"},"author":{"name":"Nogoy\u00e1 Times","@id":"https:\/\/nogoyatimes.com\/#\/schema\/person\/ada1fd8d2cdb970395179b53a1ff1759"},"headline":"Vacuna contra el c\u00e1ncer: Rusia comenzar\u00e1 los ensayos en humanos","datePublished":"2025-08-06T11:42:10+00:00","mainEntityOfPage":{"@id":"https:\/\/nogoyatimes.com\/?p=29491"},"wordCount":629,"publisher":{"@id":"https:\/\/nogoyatimes.com\/#organization"},"image":{"@id":"https:\/\/nogoyatimes.com\/?p=29491#primaryimage"},"thumbnailUrl":"https:\/\/nogoyatimes.com\/wp-content\/uploads\/2025\/08\/1-8.png","articleSection":["Internacionales","Noticias"],"inLanguage":"es-AR"},{"@type":"WebPage","@id":"https:\/\/nogoyatimes.com\/?p=29491","url":"https:\/\/nogoyatimes.com\/?p=29491","name":"Vacuna contra el c\u00e1ncer: Rusia comenzar\u00e1 los ensayos en humanos - Nogoy\u00e1 Times","isPartOf":{"@id":"https:\/\/nogoyatimes.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nogoyatimes.com\/?p=29491#primaryimage"},"image":{"@id":"https:\/\/nogoyatimes.com\/?p=29491#primaryimage"},"thumbnailUrl":"https:\/\/nogoyatimes.com\/wp-content\/uploads\/2025\/08\/1-8.png","datePublished":"2025-08-06T11:42:10+00:00","breadcrumb":{"@id":"https:\/\/nogoyatimes.com\/?p=29491#breadcrumb"},"inLanguage":"es-AR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nogoyatimes.com\/?p=29491"]}]},{"@type":"ImageObject","inLanguage":"es-AR","@id":"https:\/\/nogoyatimes.com\/?p=29491#primaryimage","url":"https:\/\/nogoyatimes.com\/wp-content\/uploads\/2025\/08\/1-8.png","contentUrl":"https:\/\/nogoyatimes.com\/wp-content\/uploads\/2025\/08\/1-8.png","width":789,"height":471},{"@type":"BreadcrumbList","@id":"https:\/\/nogoyatimes.com\/?p=29491#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/nogoyatimes.com\/"},{"@type":"ListItem","position":2,"name":"Vacuna contra el c\u00e1ncer: Rusia comenzar\u00e1 los ensayos en humanos"}]},{"@type":"WebSite","@id":"https:\/\/nogoyatimes.com\/#website","url":"https:\/\/nogoyatimes.com\/","name":"Nogoy\u00e1 Times","description":"Diario Digital de Nogoy\u00e1 Radios Productora","publisher":{"@id":"https:\/\/nogoyatimes.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nogoyatimes.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es-AR"},{"@type":"Organization","@id":"https:\/\/nogoyatimes.com\/#organization","name":"Nogoy\u00e1 Times","url":"https:\/\/nogoyatimes.com\/","logo":{"@type":"ImageObject","inLanguage":"es-AR","@id":"https:\/\/nogoyatimes.com\/#\/schema\/logo\/image\/","url":"https:\/\/nogoyatimes.com\/wp-content\/uploads\/2023\/05\/cropped-nogoyatimes-a.jpg","contentUrl":"https:\/\/nogoyatimes.com\/wp-content\/uploads\/2023\/05\/cropped-nogoyatimes-a.jpg","width":250,"height":112,"caption":"Nogoy\u00e1 Times"},"image":{"@id":"https:\/\/nogoyatimes.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nogoyatimes.com\/#\/schema\/person\/ada1fd8d2cdb970395179b53a1ff1759","name":"Nogoy\u00e1 Times","url":"https:\/\/nogoyatimes.com\/?author=2"}]}},"_links":{"self":[{"href":"https:\/\/nogoyatimes.com\/index.php?rest_route=\/wp\/v2\/posts\/29491","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nogoyatimes.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nogoyatimes.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nogoyatimes.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nogoyatimes.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=29491"}],"version-history":[{"count":1,"href":"https:\/\/nogoyatimes.com\/index.php?rest_route=\/wp\/v2\/posts\/29491\/revisions"}],"predecessor-version":[{"id":29493,"href":"https:\/\/nogoyatimes.com\/index.php?rest_route=\/wp\/v2\/posts\/29491\/revisions\/29493"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nogoyatimes.com\/index.php?rest_route=\/wp\/v2\/media\/29492"}],"wp:attachment":[{"href":"https:\/\/nogoyatimes.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=29491"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nogoyatimes.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=29491"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nogoyatimes.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=29491"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}